Hims & Hers Launches Menopause Care, Offers Estrogen Patches Amid Surging Demand
HIMS has more than doubled off its 52-week low of $13.74 on light trading volume (0.4× avg).
Summary
Hims & Hers is expanding its Hers platform to offer treatment options for perimenopause and menopause, including estrogen patch kits starting at $134 per month. This strategic move addresses a significant and growing market, with over 1 million women entering menopause annually and surging demand for hormone therapy. Crucially, the company states it has secured sufficient inventory to meet demand, a key competitive advantage given nationwide supply constraints for estrogen patches. This expansion into a high-demand area with a secured supply chain represents a material growth opportunity for Hims & Hers, potentially boosting future revenue and market share.
At the time of this announcement, HIMS was trading at $28.76 on NYSE in the Life Sciences sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $13.74 to $70.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.